Sirolimus

ATC L04AH01 · 11 markets · 102 records

Sirolimus 11 markets · 102 records Forms

US 39 records · 6 strengths

  • 1 mgtabletNo trade name also in GB·AU·CN +3
  • 2 mgtabletNo trade name also in GB·AU·ES
  • 0.5 mgtabletNo trade name also in AU·ES·SG
  • 1 mgliquidNo trade name also in GB·CA·ES
  • 2 mgtopicalHYFTOR also in GB
  • 5 mginjectionFYARRO

GB 10 records · 6 strengths

Records without a stated strength · 2 Rapamune 1mg tablets、__no_trade__ __no_trade__

AU 10 records · 6 strengths

Records without a stated strength · 1 Rapamune 1mg tablets

CN 8 records · 7 strengths

  • 1 mgtabletManufacturer: Pfizer Europe MAEEIG also in US·GB·AU +3
  • 50 mg/50 mLliquid宜欣可西罗莫司赛莫司
  • 1 mgcapsuleManufacturer: 华北制药股份有限公司 ×2
  • 0.5 mgcapsuleManufacturer: 华北制药股份有限公司 ×2
  • 30 mg/30 mLliquid赛莫司西罗莫司
  • 20 mg/20 mLliquid宜欣可西罗莫司
  • 10,000 mgtopicalManufacturer: Nobelpharma Co.,Ltd.

CA 4 records · 2 strengths

ES 4 records · 4 strengths

HK 3 records · 1 strengths

    Records without a stated strength · 1 Rapamune 1mg tablets、Rapamune 1mg/ml oral solution

    SG 2 records · 2 strengths

    TW 2 records · 1 strengths

      Records without a stated strength · 1 Rapamune 1mg tablets、斥消靈錠0.5毫克、斥消靈錠1毫克

      EU 2 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 HYFTOR、Rapamune 1mg tablets

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.